Author

Kathryn Johnson

Institutions: University of Vermont, University of Vermont Medical Center, Icahn School of Medicine at Mount Sinai

Observed institutions: University of Vermont, University of Vermont Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

ORCID: 0009-0006-6157-3832

Observed ORCID: 0009-0006-6157-3832

OpenAlex ID: A5013929903

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2023 · John Mascarenhas, Anna Rita Migliaccio, et al. · Clinical Cancer Research · 36

Team science competencies for clinical research professionals: A multileveled Delphi approach

2024 · Angela Mendell, Jessica Fritter, et al. · Journal of Clinical and Translational Science · 6

444 Team Science Competencies for Clinical Research Professionals: Determining Skills and Leveling Through a Modified Delphi Approach

2023 · Angela Mendell, Jessica Fritter, et al. · Journal of Clinical and Translational Science · 2

Supplementary Figure S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S5 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S8 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S6 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S9 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S7 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

2025 · John Mascarenhas, Anna Rita Migliaccio, et al.

Human Subjects Research and Quality Improvement Projects: What's the Difference?

2025 · Christa Varnadoe, Kathryn Johnson · AJN American Journal of Nursing

Supplementary Figure S2 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S4 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Figure S6 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S4 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S3 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S2 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S1 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Supplementary Table S3 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis

2024 · John Mascarenhas, Anna Rita Migliaccio, et al.

Works count: 100

Citation count: 44

H-index: 2

I10-index: 1